VPHM Financial Facts
Research and development: 18.09MTotal costs and expenses: 102.36M
See Full Income Statement
Inventory: 100.12M
Total assets: 1.14B
See Full Balance Sheet
ViroPharma Inc. (VPHM) Earnings
|
Expand Research on VPHM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +552.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/25/12  |
Q312 | -$0.07 | $0.02 | -$0.09 | $91M | $98.62M |  |
 | | Details | |
| 1/10/12 |
 |
Q411 | N/A | $0.41 | N/A | N/A | $143.55M | N/A | N/A | N/A | |
| 8/9/12 |
Q212 | $0.09 | $0.12 | -$0.03 | $94.6M | $104.27M | |
| | Details | |
| 2/27/13 |
|
Q412 | $0.10 | $0.03 | +$0.07 | $106.5M | $103.06M | = | | | Details |
| 5/1/13 |
|
Q113 | $0.15 | $0.04 | +$0.11 | $107M | $108.47M | = | | | Details |
| 8/1/13 |
|
Q213 | $0.15 | $0.01 | +$0.14 | $104M | $105.06M | = | | | Details |
| 10/31/13 |
|
Q313 | $0.20 | $0.05 | +$0.15 | $113M | $113.35M | = | | | Details |
| 5/1/12 |
Q112 | $0.37 | $0.42 | -$0.05 | $135.8M | $149.16M | |
| | Details |
